Protein transduction domains (PTDs), such as the HIV1-TAT peptide, have been previously used to promote the uptake of proteins into a range of cell types, including stem cells. Here we generated pancreatic transcription factors containing PTD sequences and administered these to endoderm enriched mouse embryonic stem (ES) cells under conditions that were designed to mimic the pattern of expression of these factors in the developing pancreas. The ES cells were first cultured as embryoid bodies and treated with Activin A and Bone morphogenetic protein 4 (BMP4) to promote formation of definitive endoderm. Cells were subsequently plated as a monolayer and treated with different combinations of the modified recombinant transcription factors Pdx1 and MafA. The results demonstrate that each transcription factor was efficiently taken up by the cells, where they were localized in the nuclei. RT-qPCR was used to measure the expression levels of pancreatic markers. After the addition of Pdx1 alone for a period of five days, followed by the combination of Pdx1 and TATMafA in a second phase, up-regulation of insulin 1, insulin 2, Pdx1, Glut2, Pax4 and Nkx6.1 was observed. As assessed by immunocytochemistry, double positive insulin and Pdx1 cells were detected in the differentiated cultures. Although the pattern of pancreatic markers expression in these cultures was comparable to that of a mouse transformed b-cell line (MIN-6) and human islets, the expression levels of insulin observed in the differentiated ES cell cultures were several orders of magnitude lower. This suggests that, although PTD-TFs may prove useful in studying the role of exogenous TFs in the differentiation of ES cells towards islets and other pancreatic lineages, the amount of insulin generated is well below that required for therapeutically useful cells.
Introduction
Type 1 diabetes is an autoimmune disease, in which the b-cells in the islets of Langerhans are specifically destroyed. The disease is currently treated with multiple daily injections of insulin, however it is very difficult using exogenous insulin to prevent hypoglycaemic episodes and the debilitating late complications of the disease. Islet transplantation may represent a potential form of treatment [1] , but the poor availability of donor tissue prevents its widespread use. For this reason alternative sources of b-cells from human pluripotent cells has been sought [2] .
Most of the protocols that have been established to drive pluripotent cells towards the b-cell lineage involve inducing the formation of a definitive endoderm (DE) enriched population by using Activin A [3, 4] , a member of the TGFb family of growth factors. From there the cells are directed down a differentiation pathway that mimics the events that occur in the developing mouse [5] . The idea is to recapitulate the pattern of expression of key transcription factors, including Pdx1, Ngn3, NeuroD, Nkx6.1, Pax4, and MafA, that define the b-cell lineage [6] . This approach has been validated by controlling the temporal expression of an exogenous Pdx1 gene in ES cells that have been stably transfected with a tetracycline responsive Pdx1 DNA construct [6] . This ability to fine tune the activity of key transcription factors in a dose and time dependent manner may overcome some of the challenges in generating functional b-cells in vitro.
Most cells are designed to prevent non-specific uptake of proteins. However, certain viruses have circumvented this by generating proteins that contain protein transduction domains (PTDs) [7] . Thus the PTD of the HIV1-TAT protein has been exploited in cell engineering because of its effectiveness and small size [8, 9] , and TAT-fused proteins have been shown to be efficiently taken up by a variety of cells, including ES cells [10] [11] [12] .
In the present study we used PTD-mediated uptake of Pdx1 and MafA into DE-enriched mouse ES cells. These transcription factors were added in a manner that mimicked the temporal pattern of expression in the mouse embryo. The results showed that insulin expressing b-like cells could be generated. However, although a similar expression pattern of pancreatic markers was observed for the differentiated ES cells, insulin expression levels were very much lower when compared to those of the MIN-6 bcell line or human islets, suggesting that PTD-TFs may have a limited role in protocols designed at generating ES-derived islet cells for therapeutic purposes.
Methods

Cell Culture
HeLA cells (ATCC, Teddington, UK) were cultured in Dulbecco's Modified Medium (DMEM) containing 15% foetal calf serum (FCS). The mouse CGR8 ES cell line [13] was cultured on gelatin coated tissue culture dishes in medium composed of KO-DMEM supplemented with 15% KO Serum Replacement, 16 nonessential amino acids, 16 L-glutamine, 1% b-mercaptoethanol (all from Invitrogen, Paisley, UK) and leukemia inhibitory factor (LIF). CGR8 differentiation was done in chemically defined medium (CDM) [14] composed of Iscove's Modified Dulbecco's Medium/F12, 16 chemically defined lipids (both from Invitrogen), 7 mg/ml insulin, 5 mg/ml BSA, 450 mM monothioglycerol (all from Sigma, Dorset, UK), 15 mg/ml transferrin (Roche Diagnostics, West Sussex, England) in suspension cultures for embryoid bodies (EBs) formation. For DE formation cells were cultured as EBs in CDM supplemented with 100 ng/ml Activin A and 10 ng/ml BMP-4 for 2 days and with Activin A alone for another 4 days [6] . For pancreatic differentiation EBs were plated in cell culture plates covered with Matrigel TM . Cells were then cultured for 21 days in KO-DMEM in the absence or presence of 1 mM Pdx1 and/or TAT-MafA. MIN6 cells (ATCC, Teddington, UK) were cultured in DMEM containing 25 mM glucose supplemented with 15% FCS (both from Gibco) and 70 mM b-Mercaptoethanol (Sigma).
Human Islets
Human islets of Langerhans were obtained with appropriate ethical approval in place. Upon arrival the fresh islet tissue was stored in TrizolH reagent (Invitrogen) for subsequent RNA extraction and RT-qPCR analysis.
Vector construction and protein purification
The His6-Pdx1 construct was generated by inserting the coding sequence of human Pdx1 into a pQE-31 expression vector (Qiagen, West Sussex, UK). The His6-TAT-MafA and the His6-TAT-Pdx1 constructs were generated by inserting mouse MafA and human Pdx1 coding sequences into a pET 28b TAT vector. These constructs were used to transform the competent E. coli strain BL21 (DE3) (Invitrogen). Transformed BL21 (DE3) cultures expressing the protein of interest were used to inoculate 2 L of LB medium supplemented with kanamycin and ampicillin and grown for 1.5 h at 37uC (25uC for Pdx1 cultures). IPTG (isopropyl b-D-1 thiogalactopyranoside) was added to the cultures 4 h before harvesting. Cell pellets were lysed in 8 M Urea, 0.1 M NaH 2 PO 4 at pH 8.0 for 1 h. Cell debris was removed by centrifugation and the cleared lysate was applied to a His-select affinity column (Sigma) pre-equilibrated with lysis buffer. The column was washed with 8 M Urea, 0.1 M NaH 2 PO 4 at pH 6.3 and proteins were eluted in 8 M Urea, 0.1 M NaH 2 PO 4 at pH 4.5. Protein fractions were diluted 406 in 20 mM Tris pH 7.6, incubated overnight at 4uC and re-concentrated using a 10 kDa Amicon Centrifugal filter unit (Millipore, Livingston, UK). Final protein concentration was assessed with the Biorad protein assay.
SDS-PAGE and Western Blotting
Protein aliquots were diluted in NuPage Loading Buffer, run on a 10%, 1 mm, Bis-Tris polyacrylamide gel (both from Invitrogen) and stained with Coomassie Brilliant Blue. Gels used for immunoblotting were transferred to a nitrocellulose membrane, and probed with rabbit anti-Pdx1 antibody [6] , 1:1000 or rabbit anti-MafA antibody, 1:200 (Santa Cruz Biosciences, Heidelberg, Germany). Subsequently, blots were incubated with a horseradish peroxidase conjugated anti-rabbit IgG antibody (1:5000).
RT-qPCR
RNA was extracted using TrizolH reagent (Invitrogen). After digestion with DNase I (Invitrogen) to remove any contaminating DNA, 1 mg of RNA was used for cDNA synthesis. Quantitative Polymerase Chain Reactions (RT-qPCRs) were then performed using the TaqMan gene expression assays (Tables 1 and 2 , Applied Biosystems, Paisley, UK). Real-time PCR mixtures were prepared as described by the manufacturer (SensiMiX, Bioline, London, UK) for each gene, denatured at 95uC for 15 seconds and then cycled at 95uC for 30 seconds, 60uC for 30 seconds and 72uC for 10 seconds during 50 cycles, followed by final extension at 72uC for 10 minutes. QPCRs were run in a Roche Lightcycler 480H in triplicate and normalized to GAPDH in the same run. Data was normalized to mouse embryonic stem cells or untreated cells, using the 2 2DDCT method [15] . Statistical analysis was performed using One Way ANOVA.
Immunocytochemistry
Cells were washed in Phosphate Buffer Saline (PBS) and fixed in 4% paraformaldehyde (PFA). Permeabilisation was done by incubating the cells in ice cold methanol at 220uC for 10 min followed by washing in PBS. Non-specific interactions were blocked with 10% goat serum in Tris Buffer Saline with 0.01% Triton X-100 (TBST) (Sigma). Cells were stained with rabbit antiPdx1 ( 
Immunohistochemistry
Embryoid bodies (EBs) were washed in PBS and fixed in 4% PFA overnight at 4uC followed by embedding in 1% agarose prior to paraffin embedding and sectioning. All sections were cut at a 5 mm thickness. For immunofluorescent staining sections were subjected to heat induced antigen retrieval for 15 min using Tris-EDTA Buffer, pH 9.0 and blocked with 10% goat serum in TBST. The samples were then incubated with primary antibodies rabbit anti-Sox7 (1:100, Abcam) or rabbit anti-Sox17 (1:100, Santa Cruz Biotechnology), overnight at 4uC. Sections were then probed with anti-rabbit AlexaFluor 488 (1:400, Invitrogen) for 1 h at room temperature. Slides were mounted in Vectashield with DAPI (Vector Labs).
Results
Purification and Uptake of PTD-Transcription Factors
We have previously shown that mouse and human ES cells can be directed towards an endocrine pancreatic lineage by regulating the expression of the homeodomain transcription factor Pdx1 in response to 49 hydroxytamoxifen added to the culture media [6] . In the present study we intended to determine whether the activity of Pdx1 could be modulated by adding the transcription factor directly to the cells. In addition, we would extend the study to include the bZIP factor MafA, which plays a role in the late stages of b-cell differentiation [16, 17] . The approach involved generating recombinant transcription factors that were engineered to contain PTD sequences from the HIV1-TAT protein. This was achieved by inserting the cDNAs corresponding to Pdx1 and MafA into pET28b expression vectors, which contain the sequence of the HIV1-TAT protein transduction domain. Given that the Pdx1 sequence already codes for an Antennapedia like protein transduction domain [18] , the Pdx1 sequence was also cloned into the expression vector pQE-31, which does not contain the TAT sequence (Fig. 1A ). These three vectors were then amplified in Escherichia coli BL21 (DE3), followed by purification of Pdx1, TATPdx1 and TAT-MafA by histidine affinity chromatography. The purity of the proteins obtained was assessed by SDS-PAGE (Fig. 1B) , and the identity of each transcription factor confirmed by Western Blotting and Mass Spectrometry (data not shown). To determine the ability of the purified proteins to translocate into mammalian cells, each protein was added to the culture medium of HeLa cells to a final concentration of 1 mM. Nuclear uptake of the transcription factors was found to be time dependent, with a maximum of nuclear protein detected after addition of the PTDtranscription factors to the cells for a period of 5 hours. No major difference was detected in Pdx1 and TAT-Pdx1 uptake by the HeLa cells after the 5 hour period (Fig. 1C) . For this reason, and because TAT-Pdx1 appeared to be subjected to higher amounts of degradation during the purification procedure (Fig. 1B) , the subsequent studies were carried out with Pdx1 rather than TATPdx1.
To determine whether Pdx1 and TAT-MafA could be efficiently taken up into mES cells, each protein was added to the mES culture media for a period of 4 hours. After this incubation period, both transcription factors were detected in the cells by immunostaining, with 63.7611.7% and 23.866.1% of cell nuclei positive for Pdx1 and TAT-MafA, respectively. Neither of these transcription factors was detected in untreated mES cells (Fig. 1D, E) , indicating that mouse ES cells do not endogenously express Pdx1 or MafA. Collectively these results indicate that recombinant Pdx1 and TAT-MafA are able to directly translocate into the nuclei of mES cells.
Activin A and BMP-4 Induce Definitive Endoderm formation in mESCs
In the mouse, the pancreas develops from the definitive endoderm [19] . Activin A as a surrogate for Nodal signalling acts as the master inducer of definitive endoderm formation (DE) in culture [3] . It has also been shown that BMP-4 is necessary for promoting DE formation by inducing the formation of the intermediate layer mesendoderm, while Activin A further induces DE differentiation [6] . In this study a similar approach was used to derive DE from mES cells. Undifferentiated mES cells were cultured as embryoid bodies (EBs) for 2 days in chemically defined medium (CDM) containing BMP-4 and Activin A to induce mesendoderm formation. After this period, the EBs were cultured in CDM containing Activin A alone for another 4 days ( Fig. 2A) . Mesendoderm markers Mixl1 and Gsc were up regulated at day 4 of the differentiation protocol, suggesting that at this stage an intermediary mesendoderm population was being generated. At day 4 the DE markers Sox17 and Foxa2 were already highly upregulated, indicating that some of the cells had already reached the definitive endoderm differentiation stage. A stronger up-regulation of these endoderm markers was observed at the final stage of the differentiation protocol (day 6), accompanied by the downregulation of the mesendoderm markers Mixl1 and Gsc, suggesting that more cells in the culture had undergone the transition from mesendoderm to DE (Fig. 2B) . This protocol generated an endoderm enriched cell population, which was characterized by the up-regulation of the definitive endoderm markers Sox17 and Foxa2, while the mesoderm marker Brachyury T and the extraembryonic endoderm marker Sox7 were not detected in treated cells (Fig. 2B) . These results were confirmed at the protein level by immunocytochemistry, where no Sox7 was detected at either day 4 or day 6 in treated cells, while non treated EBs presented high expression levels of this marker (Fig. 3, top panel) . The endoderm marker Sox17 was detected in both non treated and differentiated cells at day 4, however at the end of the differentiation protocol nearly all cells were positive for Sox17 in DE enriched EBs, while non treated cells had lost the expression of the DE marker (Fig. 3, bottom panel) . These results indicate that a DE enriched population was efficiently generated after Activin A and BMP-4 treatment.
It was important to determine whether the DE-enriched population of cells would be able to take up the recombinant PTD Transcription Factors (PTD-TFs) from the culture medium. To do this, DE enriched EBs were plated in culture dishes covered with Matrigel TM and allowed to attach for a period of 5 days. On the fifth day of culture the cells were incubated with 1 mM of Pdx1 or TAT-MafA for a period of 4 hours. Staining of the treated cells with specific MafA or Pdx1 antibodies revealed that over 80% of cells were positive for either Pdx1 or MafA (Fig. S1 ), while nontreated DE-enriched EBs did not express any of the pancreatic transcription factors. These results indicated that the PTD-TFs are also efficiently taken up by ES cells differentiated towards definitive endoderm, thus establishing the conditions necessary for mimicking their expression during pancreatic development.
PTD-Transcription factors drive DE progenitors towards insulin-producing cells
To differentiate further the mES cells from DE towards the bcell phenotype, the recombinant transcription factors Pdx1 and TAT-MafA were administered to the cells in a way that mimics pancreatic development observed in vivo. It is known that during pancreatic development Pdx1 is expressed in a biphasic manner, in which the first wave of Pdx1 expression is necessary to specify the pancreatic domain in the primitive foregut [20, 21] , while the second wave of Pdx1 expression drives the further differentiation of b-cells [22] . In order to simulate this process in vitro, the DE enriched cells were first plated in cell culture dishes and allowed to attach for 5 days. Subsequently, the cells were cultured in the absence or presence of 1 mM Pdx1 for a 5 day period and, again in a second phase, from day 15 to 21 ( Fig. 4A) . In the second phase of treatment, TAT-MafA was added simultaneously with Pdx1 in order to recapitulate the expression pattern observed during in vivo pancreatic development. To determine whether at this later stage Pdx1 or MafA alone would be able to drive the cells towards the bcell phenotype, these transcription factors were also independently added to the culture (Fig. 4A) . After 21 days in culture in the presence of the PTD transcription factors the differentiated cells were harvested and their mRNA levels analysed by RT-qPCR (Fig. 4B) . When Pdx1 was added to the culture medium only once, from day 5 to day 10, no pancreatic or liver markers were upregulated when compared to cells that were not treated with PTDproteins, suggesting that the first wave of Pdx1 expression was not sufficient to promote formation of b-cells or the pancreatic domain in vitro. Similar results were obtained when Pdx1 or TAT-MafA were added independently to the culture during the second expression wave that should drive the formation of b-cells (Fig. 4B) . However, when both Pdx1 and TAT-MafA were added simultaneously to the culture, up-regulation of the mouse insulin 1 and 2 genes was observed, as well as the endogenous b-cell transcription factors Pdx1, Nkx6.1, Pax4, NeuroD and the transporter Glut2 (Fig. 4B) . Along with the expression of these b-cell markers, other endocrine pancreatic markers were increased, such as the d-cell marker somatostatin and the exocrine cell marker amylase (Fig. 4B) . The fact that the endocrine precursor Ngn3 was decreased in the cells treated with Pdx1 and TAT-MafA is in keeping with the fact that mature beta cells lose the expression of this precursor after differentiation [23] . The liver marker albumin was also up-regulated after this treatment (Fig. 4B) , suggesting that a mixed population of cells was obtained, with both liver and pancreatic phenotypes present.
In order to characterize further the phenotype of the cells obtained after the treatment with the combination of PTD-TFs, immunocytochemistry was performed to assess whether the b-cell markers insulin and Pdx1 were present at the protein level (Fig. 5) . Double positive insulin and Pdx1 producing cells were detected in cells treated with the combination of Pdx1 and TAT-MafA (P+M cells), while neither insulin nor Pdx1 was detected in cells grown in the absence of the transcription factors. In order to assess whether the detected insulin was being produced de novo by the differentiated cells, staining for C-peptide was performed (Fig. 6 ), confirming that insulin was being produced by the cells and not taken up from the media. C-peptide staining was observed in 83.0%610.6 (n = 3) of the treated cultures, indicating that the majority of the cells in culture were differentiated towards the bcell lineage.
There were a number of interesting features when the pattern of expression of markers in P+M cells was compared with RNA extracted from mouse MIN6 b-cells and human islets (Fig. 7) . The MIN6 and P+M cells expressed higher levels of insulin 2 than insulin 1, with roughly equivalent relative levels of Pdx1, Ngn3, NeuroD and Nkx6.1 and relatively higher levels of MafA and the transporter Glut2 in P+M cells. The same was true when P+M cells were compared with human islets, which being a mixed cell population expressed high levels of the somatostatin, glucagon and IAPP. The fact that these were expressed at levels substantially lower than insulin 1 and 2 in P+M cells suggested that the PTD-TF mediated differentiation was preferentially directed towards bcells. However, the striking observation was the extremely low levels of insulin mRNAs in the P+M cells compare to that in the MIN6 cells or human islets. 
Discussion
Advances in islet transplantation [1] , albeit limited [24] , have been hindered by a dependence on the availability of cadaveric tissue, and stimulated a drive towards generating a replenishable supply of islets from human pluripotent cells. Despite huge progress in the differentiation of embryonic stem (ES) cells towards pancreas, it has been impossible at this stage to generate a fully functional b-cell in vitro, i.e. one that secretes meaningful amounts of insulin in response to glucose in the physiological concentration range [2] . The in vitro differentiation of pluripotent cells towards pancreatic lineages is dependent on the addition to the culture media of growth factors and small molecule inhibitors that recreate cell signaling events that occur in the developing embryo. These signaling pathways intersect within the nucleus to establish transcriptional networks that change during the course of development. The importance of these networks was emphasized in our previous study, in which we used a tetracycline-regulatable system to control the activity of an exogenous Pdx1 gene. Thus subtle changes in its temporal expression had a significant effect on the developmental outcome [6] . At present it is possible to generate pancreatic progenitors that can further differentiate into islet-like structures following engraftment in immunocompromised mice [25] . The in vivo environment can therefore recapitulate the conditions necessary to establish these networks. We surmised therefore that some of the challenges in generating functional bcells in vitro might be overcome by adding exogenous transcription factors directly to the culture medium.
PTD-TFs have previously been used to study the developing or regenerating pancreas. Thus, administration of a TAT-Ngn3 fusion protein to cultured E9.5 and E13.5 pancreatic explants resulted in efficient uptake and nuclear localisation and an increased level of endocrine differentiation compared to control samples [26] , while intraperitoneal injection of recombinant Pdx1 into streptozotocin diabetic mice restored euglycaemia through a combination of b-cell regeneration and liver reprogramming [27] . Here we show that the levels of intracellular Pdx1 can be manipulated by adding Pdx1 protein directly to the culture media. When used in combination with a PTD-MafA protein, we were able to differentiate DE-enriched mES cells towards a population of cells that co-expressed Insulin and endogenous Pdx1, and expressed some of the phenotypic characteristics of a b-cell. The outcome was dependent on adding Pdx1 in two spatially separated phases and the presence of both Pdx1 and PTD-MafA in the second phase.
Although in the present study we were able to detect Insulin mRNA and protein by immunocytochemistry, the levels were below the sensitivity of our C-peptide and insulin assays. Importantly, however when P+M cells were compared with MIN6 b-cells and human islets, although some similarities were found, there were sufficient differences to suggest that additional TFs such as Ngn3, NeuroD and Pax4 that have been shown to play an important role in reprogramming towards islet cells [28, 29] might be required to induce the formation of a more mature b-cell population. Importantly, the levels of expression of insulin mRNA was small when compared to those found in MIN6 cells and human islets. There may be isolated high insulin expressing cells within the P+M population, but this is unlikely since the immunocytochemistry indicated a very even pattern of expression throughout the culture. Although we have shown that the majority of the differentiated ES cells were driven towards insulin producing cells, low mRNA levels of the liver marker albumin were also detected in our cultures. Pancreas and liver share a common endodermal origin and the incomplete differentiation of some of the cells present in our cultures might have resulted in the formation of small numbers of cells of the hepatic lineage.
In conclusion, the present study shows that PTD-TFs can be added to ES cell cultures in a dose and temporal dependent manner. This strategy may provide important insights into the role of TFs in the differentiation of ES cells towards pancreatic lineages, and may inform strategies towards obtaining a more differentiated b-cell in vitro. However, as seen in our related study on the reprogramming of AR42-J exocrine cells [28] , PTD-TFs are unlikely to play a major role in generating ES-derived islet cells for therapeutic purposes, because of the low levels of insulin expression obtained when compared with mature b-cells. 
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